Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...

The company offers year-round educational services on the conditions, using this month in particular to guide patients to ...

Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

As part of the Johns Hopkins Wilmer Eye Institute’s MACULA 2025 and the 5th Annual Retina Festival, Christina Y. Weng, MD, MBA, gave a presentation titled “Home Monitoring for Age-Related Macular ...

Panelists discuss how real-world evidence provides crucial insights into treatment effectiveness across diverse patient populations and clinical settings while highlighting challenges in maintaining ...

Video content above is prompted by the following: How strictly do you adhere to the loading dose recommendations for new therapies in treatment-naive patients with neovascular age-related macular ...

In his presentation, David S. Boyer, MD will present data from the sozinibercept Phase 2b wet AMD trial which demonstrated that superior vision and anatomic outcomes were observed with sozinibercept 2 ...

Panelists discuss how both medications demonstrate favorable safety profiles in clinical trials, with aflibercept 8 mg benefiting from extensive 2-mg safety data, while acknowledging the need to ...

Panelists discuss how faricimab’s dual inhibition of Ang-2 provides additional benefits in vascular stability and inflammation reduction beyond VEGF-A suppression alone, potentially leading to ...